Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination
- PMID: 766800
- PMCID: PMC2025018
- DOI: 10.1038/bjc.1975.284
Chemotherapy of advanced breast cancer: a controlled randomized trial of cyclophosphamide versus a four-drug combination
Abstract
Ninety-nine patients with advanced breast cancer were randomized to receive either cyclophosphamide continuously or a combination of cyclophosphamide, methotrexate, 5-fluorouracil and vinblastine given intermittently. The number and duration of objective responses were greater in patients receiving the combination but the differences between the two treatments did not achieve formal significance. The combination was logistically easier to manage and produced less toxicity.
Similar articles
-
Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.Cancer Treat Rep. 1977 Jan-Feb;61(1):47-50. Cancer Treat Rep. 1977. PMID: 324620 Clinical Trial.
-
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.Cancer. 1978 May;41(5):1649-57. doi: 10.1002/1097-0142(197805)41:5<1649::aid-cncr2820410501>3.0.co;2-j. Cancer. 1978. PMID: 348293 Clinical Trial.
-
Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.Prog Clin Biol Res. 1977;12:459-66. Prog Clin Biol Res. 1977. PMID: 335404 Clinical Trial. No abstract available.
-
The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?Cancer Clin Trials. 1981 Winter;4(4):363-9. Cancer Clin Trials. 1981. PMID: 7032731 Review.
-
Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer.Clin Oncol (R Coll Radiol). 2001;13(6):438-40. doi: 10.1053/clon.2001.9308. Clin Oncol (R Coll Radiol). 2001. PMID: 11824881 Review.
Cited by
-
Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?Breast Cancer Res Treat. 1983;3(2):117-27. doi: 10.1007/BF01803554. Breast Cancer Res Treat. 1983. PMID: 6351947 Review.
-
Chemotherapy of breast cancer.Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139. Med Oncol Tumor Pharmacother. 1984. PMID: 6400037 Review.
-
Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer.Cancer Chemother Pharmacol. 1980;4(1):43-5. doi: 10.1007/BF00255457. Cancer Chemother Pharmacol. 1980. PMID: 7363400
-
Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group.Br J Cancer. 1989 Feb;59(2):227-30. doi: 10.1038/bjc.1989.46. Br J Cancer. 1989. PMID: 2649130 Free PMC article. Clinical Trial.
-
Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer.Br J Cancer. 2002 Nov 4;87(10):1072-8. doi: 10.1038/sj.bjc.6600626. Br J Cancer. 2002. PMID: 12402144 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources